Urinalysis Market Report
Urinalysis Market by Product (Instruments and Consumables), Application (UTIs, Kidney Disease, Liver Disease, Diabetes, Hypertension, and Others), End-user (Hospitals, Clinical Laboratories, Home Healthcare, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028
Global Urinalysis Market Analysis
According to the urinalysis market forecast, the global market size is estimated to cross $4,776.9 million by 2028, growing from $2,944.0 million in 2020, at a CAGR of 6.3%.
Rising geriatric population along with the significant rise in age-related disorders to drive the global urinalysis market.
However, a high investment cost may obstruct the growth of the global urinalysis market
According to the regional analysis of the urinalysis market, the Asia-Pacific market is anticipated to surge at a CAGR of 7.1%, by registering a revenue of $902.8 million, during the forecast period.
The urinalysis is an examination of urine to detect and manage a broad range of disorders, including kidney disease, diabetes, and urinary tract infections (UTIs). A urinalysis primarily involves checking the concentration content and appearance of the urine. Other terminologies for it are urine analysis, urine test, and UA.
COVID-19 Impact on Urinalysis Market
In response to the Covid-19 pandemic, business sector namely transportation, petroleum, retail, and tourism industry have been forced to reconsider their business models and policies. Furthermore, global urinalysis market has also witnessed declined growth, throughout the pandemic period mainly because of disruption in the supply chain and temporary halt of production operations. Also, the communal transmission of COVID-19 severely impacted the sales of majority of the firms.
On the other hand, key players operating in the urinalysis market are coming up with effective collaborations. For instance, in January 2020, Sysmex Corporation, leading Japanese healthcare player, announced the official agreement to invest in Astrego Diagnostics AB, Sweden-based rapidly growing in-vitro diagnostic company. As per this agreement, Sysmex aims to develop and market a ‘rapid drug susceptibility test1’, an innovative urinalysis solution. Such notable investments may further create significant opportunities for the investors, post COVID-19 outbreak.
Rising Geriatric Population along with the Significant Rise in Age-related Disorders to Drive the Global Urinalysis Market
The dramatically growing geriatric population across the globe will significantly influence the global urinalysis market growth, during the forecast period. As per information published by World Health Organization (WHO), a specialized agency of the United Nations (UN) responsible for international public health, the number of people aged 65 or older is expected to surge from 524 million in 2010 to almost 1.5 billion by the end of 2050. Owing to such fast growth in the senior population, the prevalence of age-related diseases and conditions namely liver & kidney diseases and diabetes are anticipated to increase notably. The diagnosis and treatment of above-stated diseases are responsible for the rising number of prescriptions for tests like albumin, creatinine, ketones, glucose, and others. These tests are performed through urine analysis, thereby, it is predicted to have a significant impact on the urinalysis market, during the forecasted period.
To know more about global urinalysis market drivers, get in touch with our analysts here.
A High Investment Cost may Obstruct the Growth of the Global Urinalysis Market
Requirement of high investment in the development of urinalysis product manufacturing plant may restrict the global urinalysis market growth, in the analysis period. Moreover, implementation of excise tax by the U.S. government combined with stringent regulatory policies may hamper the growth of the global urinalysis market.
Extensive Increase in the Burden of Liver Diseases Particularly in the LAMEA Region to Create Enormous Opportunities for the Global Market in the Future
The prevalence of kidney and liver diseases remains high worldwide particularly in the Latin American and Middle East countries. The death rate caused by liver disease in Egypt is by far the highest across the globe, followed by other African countries. For example, as per data published in 2018 by World life expectancy, the largest global health and life expectancy databases, liver disease death rate per 100,000 patients in Egypt, Nigeria, Ivory Coast, and São Tomé is 116.0, 64.4, 62.1, and 60.7 respectively. Hence, the demand for urinalysis procedure and consumables like urine test strips is expected to grow exponentially, which will further drive the global urinalysis market, in the analysis period
To know more about global urinalysis market opportunities, get in touch with our analysts here.
By Product type
Source: Research Dive Analysis
The instruments sub-segment is expected to have the lucrative growth in the global market and register a revenue of $1,528.4 million by 2028.
Significantly growing investments in the field of medical devices, mainly owing to enormous benefits provided by integrated urine analyzers and automated urine analyzers are creating positive impact on the instruments’ sub-segment. In addition, increase in healthcare expenditure, surge in the public awareness, and growing incidence of UTIs, diabetes, and kidney disease are some important factors projected to continue to augment market growth.
Moreover, prominent players of the market are coming up with novel innovations in order to strengthen their presence worldwide. For example, in August 2018, Beckman Coulter, a Danaher Corporation company that develops medical diagnostics products, and U.S. Arkray, notable urinalysis player, announced a strategic partnership and the official release of the iQ Urinalysis Workcell. Such company inventions are further expected to create enormous opportunities, across the globe.
The consumables sub-segment is expected to have the major share in the global market and register a revenue of $3,252.4 million by 2028. The frequent purchase of products including dipsticks, reagents, and disposable owing to their recurrent usage bolsters the market growth of this sub-segment. Furthermore, key factors including surging developments in multiple urine test kits and test strips along with the constant demand for lower-cost and user-friendly consumables by end-users are also fueling the market growth.
Source: Research Dive Analysis
The UTIs sub-segment of the global urinalysis market is estimated to grow at the most notable CAGR and surpass $1,933.0 million by 2028, with a rise from $1,155.9 million in 2020.
The surging need for early diagnosis of urinary tract infections (UTIs) conditions, along with increasing awareness regarding conducting regular health check-ups is one of the crucial elements contributing to the significant share of this sub-segment. Furthermore, novel product launches are also fueling the sub-segment’s growth. For instance, in November 2019, Scanwell Health, at-home medical testing platform provider, announced the official launch of smartphone-based tests for UTIs. Through Scanwells’ collaboration with Lemonaid Health, a notable telemedicine provider for physicians, patient can get diagnosed utilizing the Scanwell app along with receiving a course of treatment and consultation from their home. Such inventions are further expected to drive the sub-segments’ growth, in the analysis period.
By End User
Source: Research Dive Analysis
The hospitals sub-segment of the global urinalysis market is estimated to have largest share and surpass $2,640.3 million by 2028, with a rise from $1,659.7 million in 2020.
The excellent health coverage and ease of accessibility of hospital-based services from multiple private and group insurance plans are several key factors contributing to the maximum share of the hospitals sub-segment. Also, modernization of healthcare facilities along with government’s favorable schemes are accelerating the growth of hospitals sub-segment.
The home healthcare sub-segment of the global urinalysis market is estimated to grow at the most notable CAGR and surpass $684.4 million by 2028, with a rise from $389.4 million in 2020. The increasing trend of automation being utilized in the urinalysis is expected to provide an ancillary force for self-test urinalysis devices. Moreover, in September 2018, inui Health, Silicon Valley based consumer medical diagnostics company, announced that it had received FDA grant for its smartphone-based home urine testing platform that can perform 5 other tests. Such company developments are also further expected to drive the sub-segments’ growth.
Source: Research Dive Analysis
The Market for Urinalysis in Asia-Pacific to be the Most Lucrative
Asia-Pacific urinalysis market accounted $524.0 million in 2020 and is expected to register a revenue of $902.8 million by 2028.
The extensively increasing need for advanced and innovative liver and kidney diseases diagnostics particularly in China, India, and South Korea is one of the key elements boosting the development of the industry. Also, one of the major factors behind this growth can be the increasing prevalence of UTIs & hypertension, lack of expertise, and the poor healthcare infrastructure in the region. In addition to this, aging population combined with technological innovations in the urinalysis industry is further expected to boost the demand for urinalysis procedures, in the region.
The North America Urinalysis Market to be the Most Dominant
North America is expected to hold the largest urinalysis market share throughout 2021–2028. North America urinalysis market accounted $1,578.0 million in 2020 and is expected to register a revenue of $2,541.3 million by 2028. The growth of North America urinalysis market is mainly driven by the implementation of favorable government initiatives, growing geriatric population, the availability of technologically advanced instruments, improved healthcare infrastructure, and rising healthcare expenditure.
Competitive Scenario in the Global Urinalysis Market
Treatment type launches and mergers & acquisitions are common strategies followed by major market players.
Source: Research Dive Analysis
Some of the leading urinalysis market players are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Cardinal Health, Inc., Abbott Laboratories, Danaher Corporation, Sysmex Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and ARKRAY, Inc.
Porter’s Five Forces Analysis for the Global Urinalysis Market:
- Bargaining Power of Suppliers: The suppliers operating in the global urinalysis are high in number and are much larger & more globalized. So, there will be less threat from the supplier.
Thus, the bargaining power of the supplier is low.
- Bargaining Power of Buyers: Buyers demand effective urinalysis procedures at lower cost. This has increased the pressure on the multiple medical devices manufacturers to offer the instruments in a cost-effective way. Thus, many suppliers have started offering best yet cost –effective urinalysis. This gives the buyers the option to freely choose urinalysis instruments that best fits their preference.
Thus, the bargaining power of the buyers is high.
- Threat of New Entrants: The companies entering the global urinalysis market are adopting technological innovations to attract customers. Also, these companies are implementing various effective strategies and there is government support in some countries.
Thus, threat of the new entrants is high.
- Threat of Substitutes: There is no alternative treatment type available.
Thus, the threat of substitutes is low.
- Competitive Rivalry in the Market: The competitive rivalry among the industry leaders is rather intense, especially between the global players including Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., and Cardinal Health, Inc. These companies are launching their value-added services in the international market and strengthening the footprint worldwide.
Therefore, the competitive rivalry in the market is high.
Historical Market Estimations
Base Year for Market Estimation
Forecast timeline for Market Projection
North America, Europe, Asia-Pacific, LAMEA
Segmentation by Product
Segmentation by Application
Segmentation by End-user
Key Countries Covered
U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, China, Japan, India, Australia, South Korea, Rest of Asia-Pacific, Brazil, Saudi Arabia, United Arab Emirates, Rest of LAMEA
Key Companies Profiled
Q1. What is the size of the urinalysis market?
A. The global urinalysis market size was over $2,944.0 million in 2020 and is projected to reach $4,776.9 million by 2028.
Q2. Which are the major companies in the urinalysis market?
A. Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., and Cardinal Health, Inc. are some of the key players in the global urinalysis market.
Q3. Which region possesses greater investment opportunities in the coming future?
A. The Asia-Pacific region possesses great investment opportunities for the investors to witness the most promising growth in the future.
Q4. What is the growth rate of the Asia-Pacific market?
A. Asia-Pacific urinalysis market is anticipated to grow at 7.1% CAGR during the forecast period.
Q5. What are the strategies opted by the leading players in this market?
A. Capacity expansion, treatment type development, along with joint ventures are the key strategies opted by the operating companies in this market.
Q6. Which companies are investing more on R&D practices?
A. Abbott Laboratories, Danaher Corporation, and Sysmex Corporation are investing more on R&D activities for developing new treatment types and technologies.
Q7. What does blood in the urine indicate?
A. Most causes of blood in urine are not serious, but sometimes red blood cells in urine can mean that patient has a medical condition like a UTI, liver disease, and kidney disease.
Q8. What does protein in urine mean?
A. If there is a disorder with patient’s kidney, then protein can be found in the urine.
Q9. What can be detected in a urine test?
A. Protein, sugar, ketones, bilirubin, and blood can be detected in the urine test.
Q10. What is specific gravity of urine?
A. Urine specific gravity is a precise measurement that shows the concentration of chemical particles in the urine.
Q11. What are the 3 parts of urinalysis?
A. Urinalysis consists of 3 components or examinations such as microscopical, physical, and chemical.
Q12. What diseases can a urinalysis detect?
A. Diseases such as kidney disease, liver disease, UTIs, and diabetes can be detected by the urinalysis.
Q13. What does a positive urinalysis mean?
A. A positive test of urinalysis is highly specific for bacterial infection of kidney or urinary tract.
1.2.Real time insights and validation
1.4.Assumptions and forecast parameters
2.2.By product type trends
2.3.By application trends
2.4.By end user trends
3.1.Market segmentation & definitions
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.3.1.Bargaining power of consumers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of new entrants
3.3.4.Threat of substitutes
3.3.5.Competitive rivalry in the market
3.8.1.by product type
3.8.3.by end user
3.9.Market value chain analysis
3.9.1.Stress point analysis
3.9.2.Raw material analysis
3.9.4.Distribution channel analysis
22.214.171.124.Raw material suppliers
4.Urinalysis Market, by Product type
4.1.1.Market size and forecast, by region, 2020-2028
4.1.2.Comparative market share analysis, 2020 & 2028
4.2.1.Market size and forecast, by region, 2020-2028
4.2.2.Comparative market share analysis, 2020 & 2028
5.Urinalysis Market, by Application
5.1.1.Market size and forecast, by region, 2020-2028
5.1.2.Comparative market share analysis, 2020 & 2028
5.2.1.Market size and forecast, by region, 2020-2028
5.2.2.Comparative market share analysis, 2020 & 2028
5.3.1.Market size and forecast, by region, 2020-2028
5.3.2.Comparative market share analysis, 2020 & 2028
5.4.1.Market size and forecast, by region, 2020-2028
5.4.2.Comparative market share analysis, 2020 & 2028
5.5.1.Market size and forecast, by region, 2020-2028
5.5.2.Comparative market share analysis, 2020 & 2028
5.6.1.Market size and forecast, by region, 2020-2028
5.6.2.Comparative market share analysis, 2020 & 2028
6.Urinalysis Market, by End User
6.1.1.Market size and forecast, by region, 2020-2028
6.1.2.Comparative market share analysis, 2020 & 2028
6.2.1.Market size and forecast, by region, 2020-2028
6.2.2.Comparative market share analysis, 2020 & 2028
6.3.1.Market size and forecast, by region, 2020-2028
6.3.2.Comparative market share analysis, 2020 & 2028
6.4.1.Market size and forecast, by region, 2020-2028
6.4.2.Comparative market share analysis, 2020 & 2028
7.Urinalysis Market, by Region
7.1.1.Market size and forecast, by product type, 2020-2028
7.1.2.Market size and forecast, by application, 2020-2028
7.1.3.Market size and forecast, by end user, 2020-2028
7.1.4.Market size and forecast, by country, 2020-2028
126.96.36.199.Market size and forecast, by product type, 2020-2028
188.8.131.52.Market size and forecast, by application, 2020-2028
184.108.40.206.Market size and forecast, by end user, 2020-2028
220.127.116.11.Market size and forecast, by product type, 2020-2028
18.104.22.168.Market size and forecast, by application, 2020-2028
22.214.171.124.Market size and forecast, by end user, 2020-2028
126.96.36.199.Market size and forecast, by product type, 2020-2028
188.8.131.52.Market size and forecast, by application, 2020-2028
184.108.40.206.Market size and forecast, by end user, 2020-2028
7.2.1.Market size and forecast, by product type, 2020-2028
7.2.2.Market size and forecast, by application, 2020-2028
7.2.3.Market size and forecast, by end user, 2020-2028
7.2.4.Market size and forecast, by country, 2020-2028
220.127.116.11.Market size and forecast, by product type, 2020-2028
18.104.22.168.Market size and forecast, by application, 2020-2028
22.214.171.124.Market size and forecast, by end user, 2020-2028
126.96.36.199.Market size and forecast, by product type, 2020-2028
188.8.131.52.Market size and forecast, by application, 2020-2028
184.108.40.206.Market size and forecast, by end user, 2020-2028
220.127.116.11.Market size and forecast, by product type, 2020-2028
18.104.22.168.Market size and forecast, by application, 2020-2028
22.214.171.124.Market size and forecast, by end user, 2020-2028
126.96.36.199.Market size and forecast, by product type, 2020-2028
188.8.131.52.Market size and forecast, by application, 2020-2028
184.108.40.206.Market size and forecast, by end user, 2020-2028
220.127.116.11.Market size and forecast, by product type, 2020-2028
18.104.22.168.Market size and forecast, by application, 2020-2028
22.214.171.124.Market size and forecast, by end user, 2020-2028
7.2.10.Rest of Europe
126.96.36.199.Market size and forecast, by product type, 2020-2028
188.8.131.52.Market size and forecast, by application, 2020-2028
184.108.40.206.Market size and forecast, by end user, 2020-2028
7.3.1.Market size and forecast, by product type, 2020-2028
7.3.2.Market size and forecast, by application, 2020-2028
7.3.3.Market size and forecast, by end user, 2020-2028
7.3.4.Market size and forecast, by country, 2020-2028
220.127.116.11.Market size and forecast, by product type, 2020-2028
18.104.22.168.Market size and forecast, by application, 2020-2028
22.214.171.124.Market size and forecast, by end user, 2020-2028
126.96.36.199.Market size and forecast, by product type, 2020-2028
188.8.131.52.Market size and forecast, by application, 2020-2028
184.108.40.206.Market size and forecast, by end user, 2020-2028
220.127.116.11.Market size and forecast, by product type, 2020-2028
18.104.22.168.Market size and forecast, by application, 2020-2028
22.214.171.124.Market size and forecast, by end user, 2020-2028
126.96.36.199.Market size and forecast, by product type, 2020-2028
188.8.131.52.Market size and forecast, by application, 2020-2028
184.108.40.206.Market size and forecast, by end user, 2020-2028
220.127.116.11.Market size and forecast, by product type, 2020-2028
18.104.22.168.Market size and forecast, by application, 2020-2028
22.214.171.124.Market size and forecast, by end user, 2020-2028
7.3.10.Rest of Asia Pacific
126.96.36.199.Market size and forecast, by product type, 2020-2028
188.8.131.52.Market size and forecast, by application, 2020-2028
184.108.40.206.Market size and forecast, by end user, 2020-2028
7.4.1.Market size and forecast, by product type, 2020-2028
7.4.2.Market size and forecast, by application, 2020-2028
7.4.3.Market size and forecast, by end user, 2020-2028
7.4.4.Market size and forecast, by country, 2020-2028
220.127.116.11.Market size and forecast, by product type, 2020-2028
18.104.22.168.Market size and forecast, by application, 2020-2028
22.214.171.124.Market size and forecast, by end user, 2020-2028
126.96.36.199.Market size and forecast, by product type, 2020-2028
188.8.131.52.Market size and forecast, by application, 2020-2028
184.108.40.206.Market size and forecast, by end user, 2020-2028
220.127.116.11.Market size and forecast, by product type, 2020-2028
18.104.22.168.Market size and forecast, by application, 2020-2028
22.214.171.124.Market size and forecast, by end user, 2020-2028
8.1.Siemens Healthineers AG
8.1.4.Recent strategic moves & developments
8.2.F. Hoffmann-La Roche Ltd.
8.2.4.Recent strategic moves & developments
8.3.Cardinal Health, Inc
8.3.4.Recent strategic moves & developments
8.4.4.Recent strategic moves & developments
8.5.4.Recent strategic moves & developments
8.6.4.Recent strategic moves & developments
8.7.Becton, Dickinson and Company
8.7.4.Recent strategic moves & developments
8.8.Bio-Rad Laboratories, Inc.
8.8.4.Recent strategic moves & developments
8.9.Thermo Fisher Scientific Inc.
8.9.4.Recent strategic moves & developments
8.10.4.Recent strategic moves & developments
Urinalysis is a series of tests that can assess wide range of health disorders with a urine sample. These tests are conducted to detect and monitor certain health conditions, such as kidney diseases, liver diseases, diabetes, or urinary tract infections. The motive of conducting this test is to find some microscopic elements, such as red blood cells, white blood cells, bacteria, and crystals which cannot be seen through bare eyes. In addition, it is a dipstick test in which a thin plastic strip quoted with chemicals is dipped into the urine samples. The change of the color of strips help to diagnose the type of health disorders and help to treat patients accordingly.
Forecast Analysis of the Global Urinalysis Market
Urinalysis is a useful test that can examine various health disorders to treat patients suffering from several chronic diseases all across the globe. Furthermore, with the increasing geriatric population together with the growing age-related disorders, the urinalysis market is expected to witness bolstering growth throughout the analysis timeframe. Moreover, the increasing prevalence of liver diseases, especially in the LAMEA region is predicted to magnify the growth of the market during the forecast timeframe. However, the high investment cost in the development of urinalysis product manufacturing plant may hinder the growth of the urinalysis market over the estimated timeframe.
According to the report published by Research Dive, the global urinalysis market is envisioned to generate a revenue of $4,776.9 million and rise at a noteworthy CAGR of 6.3% during the analysis period from 2021-2028. Regionally, the North America region is projected to hold the largest share of the market and is predicted to garner a revenue of $2,541.3 million over the forecast period. This is mainly due to the rising government initiatives, growing of technological advanced instruments and rising number of geriatric population in this region.
The major players of the urinalysis market include Danaher Corporation, Becton, Dickinson and Company, Abbott Laboratories, Sysmex Corporation, Cardinal Health, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Siemens Healthineers AG, ARKRAY, Inc. and many more.
The key companies operating in the industry are adopting various growth strategies & business tactics such as partnerships, collaborations, mergers & acquisitions, and launches to maintain a robust position in the overall market, which is subsequently helping the global urinalysis market to grow exponentially.
For instance, in November 2019, Scanwell Health, a leading provider of at-home medical testing with instant results and empowers healthcare consumers and companies, announced its collaboration with Lemonaid Health, a renowned San-Francisco based tele-health medicine service provider with nurse practitioners and physicians. With this collaboration, the customers can easily get diagnosis facility by using Scanwell app and receive a consultation with good physician and course treatment by sitting at their home.
In June 2020, Healthy.io, a leading health care company offering remote clinical testing and services, acquired inui Health, a renowned consumer medical diagnostics company that provides urinalysis at home through smartphone, for $9 million. With this acquisition, Healthy.io is aiming to expand its reach all across the United States and the companies are focusing on the transformation of a smartphone camera into a scanner to examine urine test strips with more clinical level precision.
In October 2021, Inpeco, a global leader in Automation Systems for the Clinical Laboratories, and Sysmex Europe, a renowned Germany based laboratory equipment supplier who completely believes in technological excellence, launched the next generation urinalysis solutions. The specific and important thing about this product is that it is the first bi-directional system that carries racks between the urinalysis analyzers of the Sysmex UN-Series and Inpeco’s TLA system. This product delivers a next level of completely automated urinalysis workflow solution with more flexibility.
Covid-19 Impact on the Market
With the rise of the Covid-19 pandemic, the global urinalysis market has experienced a declined growth likewise various other industries. This is mainly because of the prolonged halt of manufacturing operations and disruption in the supply chain networks due to the strict restrictions on the transportation and stringent lockdowns during the pandemic period. However, the effective collaborations made by the leading market players have created major growth opportunities for the urinalysis market.